Helicobacter pylori attachment-blocking antibodies protect against duodenal ulcer disease

Jeanna A Bugaytsova,Kristof Moonens,Artem Piddubnyi,Alexej Schmidt,Johan Olofsson Edlund,Gennadii Lisiutin,Kristoffer Brännström,Yevgen A Chernov,Kaisa Thorel,Iryna Tkachenko,Oleksandra Sharova,Iryna Vikhrova,Anna Butsyk,Pavlo Shubin,Ruslana Chyzhma,Daniel X Johansson,Harold Marcotte,Rolf Sjöström,Anna Shevtsova,Göran Bylund,Lena Rakhimova,Anders Lundquist,Oleksandra Berhilevych,Victoria Kasianchuk,Andrii Loboda,Volodymyr Ivanytsia,Kjell Hultenby,Mats A A Persson,Joana Gomes,Rita Matos,Fátima Gartner,Celso A Reis,Jeannette M Whitmire,D Scott Merrell,Qiang Pan-Hammarström,Maréne Landström,Stefan Oscarson,Mario M D'Elios,Lars Agreus,Jukka Ronkainen,Pertti Aro,Lars Engstrand,David Y Graham,Vladyslava Kachkovska,Asish Mukhopadhyay,Sujit Chaudhuri,Bipul Chandra Karmakar,Sangita Paul,Oleksandr Kravets,Margarita Camorlinga,Javier Torres,Douglas E Berg,Roman Moskalenko,Rainer Haas,Han Remaut,Lennart Hammarström,Thomas Borén
DOI: https://doi.org/10.1101/2023.05.24.542096
2023-05-24
bioRxiv
Abstract:The majority of the world population carry the gastric pathogen Helicobacter pylori. Fortunately, most individuals experience only low-grade or no symptoms, but in many cases the chronic inflammatory infection develops into severe gastric disease, including duodenal ulcer disease and gastric cancer. Here we report on a protective mechanism where H. pylori attachment and accompanying chronic mucosal inflammation can be reduced by antibodies that are present in a vast majority of H. pylori carriers. These antibodies block binding of the H. pylori attachment protein BabA by mimicking BabA's binding to the ABO blood group glycans in the gastric mucosa. However, many individuals demonstrate low titers of BabA blocking antibodies, which is associated with an increased risk for duodenal ulceration, suggesting a role for these antibodies in preventing gastric disease.
What problem does this paper attempt to address?